ChemoID Test Can Lead to Longer Glioblastoma Patient Survival
Researchers found that a cancer stem cell test called ChemoID can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma.
Read MorePosted by Melanie Hamilton-Basich | May 5, 2023 | Unknown Origin & Other Cancer Types |
Researchers found that a cancer stem cell test called ChemoID can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma.
Read MorePosted by Steve Halasey | Oct 10, 2018 | Research |
The Parsortix liquid biopsy system has provided the first evidence of circulating tumor cell clusters in the peripheral blood of glioblastoma patients.
Read MorePosted by Andy Lundin | Jan 27, 2025 | Unknown Origin & Other Cancer Types |
Researchers diagnosed leptomeningeal disease in diffuse midline gliomas by detecting H3K27M-mutant ctDNA from cerebrospinal fluid.
Read MorePosted by Andy Lundin | Aug 27, 2024 | Unknown Origin & Other Cancer Types |
A new automated device can diagnose glioblastoma in under an hour using a novel electrokinetic biochip that detects active EGFRs from blood.
Read MorePosted by Andy Lundin | Jun 19, 2024 | Sequencing Systems, Unknown Origin & Other Cancer Types |
A new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Read More